Longitudinal evaluation reveals increased liver stiffness linked to severe hepatic steatosis in patients with MASLD, highlighting fat accumulation as an early progression driver.
The predictors of progression from steatosis to more advanced stages of metabolic dysfunction-associated steatotic liver disease (MASLD) remain unclear. We evaluated the association between the quantity of hepatic steatosis and longitudinal changes in liver stiffness measurements (LSMs) using magnetic resonance elastography (MRE) in patients with MASLD.
No takes yet. Share an insight, caveat, or question.
Kumada et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: